Menu

BioLineRx Ltd. BLRX

Full chart Compare
Set alert

Price alert · BLRX

All alert types
1.71 USD -0.06 (-3.28%)

At closeNov 6, 2026, 7:30 PM EST

1.60 -0.11 -6.43%

After hours · Nov 6, 7:30 PM ET

1.71 Day range 1.75
1.71 52-week range 3.78
YTD
-38.27%
1 year
-48.65%

Revenue & Expenses

Other Income → Expenses: $9.18MExpenses → Selling, General & Admin: $3.14MExpenses → Research & Development: $7.66MGross Profit → Expenses: $430.39KRevenue → Gross Profit: $430.39KRevenue → Cost of Revenue: $758.97KNet Loss → Expenses: $1.18MOther Income$9.18MGross Profit$430.39KNet Loss$1.18MCost of Revenue$758.97KExpenses$10.80MSelling, General & Admin$3.14MResearch & Development$7.66MRevenue$1.19M

Latest period ending Dec 31, 2025 · select a line to chart its full history

BLRX annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
1.18M28.94M4.80M00
950.00K19.68M1.11M00
-10.29M-20.41M-49.69M-29.16M-24.78M
-1.18M-9.22M-60.61M-24.95M-27.05M
BLRX annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
20.88M19.56M42.99M51.08M57.13M
40.91M38.91M63.92M76.38M81.39M
17.56M25.45M50.70M25.54M13.30M
10.15M15.04M11.59M12.32M4.65M
18.20M13.46M13.22M50.84M68.09M
BLRX annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-8.07M-43.87M-22.61M-26.24M-23.57M
-8.54M29.37M1.44M4.01M-38.22M
8.88M20.66M15.06M20.44M57.75M
-25.00K-53.00K-116.00K-131.00K-97.00K
-7.74M6.16M-6.11M-1.80M-4.05M